SCHEMBL20325328

SCHEMBL20325328

C[C@@]1(COP(=O)(O)S)CC[C@H](n2cnc3c(N)ncnc32)O1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX3 P56373 3/20 0.47
P2RX1 P51575 2/20 0.47
P2RX4 Q99571 2/20 0.47
POLB P06746 1/20 0.46
P2RY1 P47900 4/20 0.45
P2RY2 P41231 3/20 0.45
P2RY11 Q96G91 2/20 0.45
DNPH1 O43598 1/20 0.45
PRKAB2 O43741 1/20 0.45
TRPM2 O94759 1/20 0.45
LDHA P00338 1/20 0.45
ADRB2 P07550 1/20 0.45
FBP1 P09467 1/20 0.45
SRC P12931 1/20 0.45
ADORA1 P30542 1/20 0.45
PRKAG1 P54619 1/20 0.45
PRKAA2 P54646 1/20 0.45
PDE4D Q08499 1/20 0.45
KCNH2 Q12809 1/20 0.45
PRKAA1 Q13131 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21298878 1.00 P2RX3 (0.47) P2RX3P2RX1P2RX4POLBP2RY1
SCHEMBL21637015 0.92 P2RY1 (0.53) P2RX3P2RX1P2RX4POLBP2RY1
SCHEMBL20325327 0.89 TAS1R3 (0.52) P2RX3P2RX1P2RX4POLBP2RY1
SCHEMBL24695057 0.82 ADA (0.54) ADORA1SMN1; SMN2PI4KAPI4K2BPI4K2A
SCHEMBL24559535 0.81 P2RX1 (0.49) P2RX3P2RX1P2RX4P2RY1P2RY2
SCHEMBL24276629 0.81 P2RX1 (0.49) P2RX3P2RX1P2RX4P2RY1P2RY2
SCHEMBL20224837 0.80 P2RX1 (0.45) P2RX3P2RX1P2RX4POLBP2RY1
SCHEMBL20325355 0.79 POLB (0.44) P2RX3P2RX1P2RX4POLB
SCHEMBL24276968 0.79 P2RY1 (0.48) P2RX3P2RX1P2RX4P2RY1P2RY2
SCHEMBL22990449 0.78 P2RY1 (0.54) POLBP2RY1P2RY2P2RY11DNPH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018118665-A1 CYCLIC DINUCLEOTIDE STING AGONISTS FOR CANCER TREATMENT MERCK SHARP & DOHME CORP. (US) 2018-06-28 WO disclosed
WO-2018118664-A1 COMBINATIONS OF PD-1 ANTAGONISTS AND CYCLIC DINUCLEOTIDE STING AGONISTS FOR CANCER TREATMENT MERCK SHARP & DOHME CORP. (US) 2018-06-28 WO disclosed